Genomics Tailored Cancer Immunotherapy

Mainz, September 13, 2013 – At the 2013 Annual Meeting of the German Society for Immunology (DGfI), TRON founder and scientific director Ugur Sahin will give a presentation on “Genomics Tailored Cancer Immunotherapy”. The plenary session on September 14 is dedicated to “New Concepts in Cancer Immunotherapy”. Sahin will present alongside Ton Schumacher from the Netherlands Cancer Institute and Vincenzo Bronte from the University of Verona.

In addition, Mustafa Diken, co-director of the TRON Immunotherapy Development Center will present a short talk about “Novel RNA-lipoplexes with immunostimulatory and targeting properties induce potent anti-tumoral immunity”. The September 13 talk is part of a session on “Therapeutic Tumor Vaccination”.
The DGfI meeting takes place September 11 to 14 at Johannes Gutenberg University in Mainz. For more information go to